Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients

AIM: To investigate the clinical utility of serum annexin A2 (ANXA2) as a diagnostic marker for early hepatocellular carcinoma (HCC). METHODS: This study was performed in HCC Clinic of Ain Shams University Hospitals, Cairo, Egypt and included: Group 1: Fifty patients with early stage HCC (Barcelona...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaker, Mohamed K, Abdel Fattah, Hanzada I, Sabbour, Ghada S, Montasser, Iman F, Abdelhakam, Sara M, El Hadidy, Eman, Yousry, Rehab, El Dorry, Ahmed K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Case Control Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368624/
https://www.ncbi.nlm.nih.gov/pubmed/28396717
http://dx.doi.org/10.4254/wjh.v9.i9.469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368624/
https://www.ncbi.nlm.nih.gov/pubmed/28396717
http://dx.doi.org/10.4254/wjh.v9.i9.469

Ejemplares similares